Talk to Robyn

(866) 682 9815

Search inside this page

All regions

Free Market Research Guides to Download

Drug Discovery and Development Analysis & Statistics, January 2013 (p35)

You might be interested in: clinical trial, drug discovery, drug development, more »

» Purchase Premium Reports

1021-1060 of about 2 900 reports

Armenia Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Armenia

Congo Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2007 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Congo, Democratic Republic Of

Burkina Faso Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Burkina Faso

Botswana Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Botswana

Afghanistan Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2007 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Afghanistan

Bangladesh Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Bangladesh

Number Of Approvals Of Registration-drug_clinical Trials Of Imported Drug-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug Discovery and Development

Australia Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2011
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Australia

Argentina Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Argentina

Number Of Approvals Of Registration-drug_imported Drug Registration-china-annual, In Unit (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Drug Discovery and Development
World Drug Discovery and Development: Hyperoxaluria - Pipeline Review, H2 2011

World Drug Discovery and Development: Hyperoxaluria - Pipeline Review, H2 2011

  • $ 500
  • Industry report
  • October 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Hyperoxaluria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Drug Discovery and Development
  • Countries : World
World Drug Discovery and Development: Chronic Idiopathic Myelofibrosis - Pipeline Review, H2 2011

World Drug Discovery and Development: Chronic Idiopathic Myelofibrosis - Pipeline Review, H2 2011

  • $ 500
  • Industry report
  • October 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Chronic Idiopathic Myelofibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also ...

  • Industries : Drug Discovery and Development
  • Countries : World, Australia
Drug Discovery and Development: AOI Medical, Inc. (AOI)

Drug Discovery and Development: AOI Medical, Inc. (AOI)

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the AOI Medical, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Drug Discovery and Development
Navigation Systems: BioQ Devices Pty Ltd

Navigation Systems: BioQ Devices Pty Ltd

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the BioQ Devices Pty Ltd portfolio of new product development . The report provides detailed analysis on each pipeline product ...

  • Industries : Drug Discovery and Development
  • Countries : Australia, United States, Japan
Cardiovascular Devices: InspireMD Ltd.

Cardiovascular Devices: InspireMD Ltd.

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the InspireMD Ltd. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Drug Discovery and Development
Drug Discovery and Development: Bioretec Ltd.

Drug Discovery and Development: Bioretec Ltd.

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Bioretec Ltd. portfolio of new product development . The report provides detailed analysis on each pipeline product with data ...

  • Industries : Drug Discovery and Development
Drug Discovery and Development: CytoSorbents Corporation (CTSO)

Drug Discovery and Development: CytoSorbents Corporation (CTSO)

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the CytoSorbents Corporation portfolio of new product development . The report provides detailed analysis on each pipeline product ...

  • Industries : Drug Discovery and Development
Drug Discovery and Development: Minos Medical Inc.

Drug Discovery and Development: Minos Medical Inc.

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Minos Medical Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Drug Discovery and Development: MCS Medical Compression Systems (DBN) Ltd. (MDCL)

Drug Discovery and Development: MCS Medical Compression Systems (DBN) Ltd. (MDCL)

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the MCS Medical Compression Systems (DBN) Ltd. portfolio of new product development . The report provides detailed analysis on ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Israel, Australia
Drug Discovery and Development: Biosign Technologies Inc. (BIO)

Drug Discovery and Development: Biosign Technologies Inc. (BIO)

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Biosign Technologies Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product ...

  • Industries : Drug Discovery and Development
Drug Discovery and Development: Resoimplant GmbH

Drug Discovery and Development: Resoimplant GmbH

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Resoimplant GmbH portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Drug Discovery and Development
  • Countries : Germany
Noveko International Inc. (EKO) - Product Pipeline Analysis

Noveko International Inc. (EKO) - Product Pipeline Analysis

  • $ 750
  • Company report
  • October 2011
  • by Global Data

Noveko International Inc. (EKO) - Product Pipeline Analysis Summary Noveko International Inc. (Noveko) is engaged in the design, development and distribution of ultrasound products and medical devices ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Israel, Algeria
Spring Health Solutions Ltd. - Product Pipeline Analysis

Spring Health Solutions Ltd. - Product Pipeline Analysis

  • $ 750
  • Company report
  • October 2011
  • by Global Data

Spring Health Solutions Ltd. - Product Pipeline Analysis Summary Spring Health Solutions Ltd. (Spring Health) is a medical device company engaged in the development of tools for Continuous Subcutaneous ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Drug Discovery and Development: STAAR Surgical Company (STAA)

Drug Discovery and Development: STAAR Surgical Company (STAA)

  • $ 750
  • Industry report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the STAAR Surgical Firms portfolio of new product development . The report provides detailed analysis on each pipeline product ...

  • Industries : Drug Discovery and Development
Drug Discovery and Development: Innovent Medical Solutions, Ltd.

Drug Discovery and Development: Innovent Medical Solutions, Ltd.

  • $ 750
  • Company report
  • October 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Innovent Medical Solutions, Ltd. portfolio of new product development . The report provides detailed analysis on each pipeline ...

  • Industries : Drug Discovery and Development
Stanmore Implants - Product Pipeline Analysis

Stanmore Implants - Product Pipeline Analysis

  • $ 750
  • Company report
  • October 2011
  • by Global Data

Stanmore Implants - Product Pipeline Analysis Summary Stanmore Implants (Stanmore) is a medical device company engaged in the design, manufacturing and marketing of limb salvage implants for saving and ...

  • Industries : Drug Discovery and Development
Aptus Endosystems, Inc. - Product Pipeline Analysis

Aptus Endosystems, Inc. - Product Pipeline Analysis

  • $ 750
  • Company report
  • October 2011
  • by Global Data

Aptus Endosystems, Inc. - Product Pipeline Analysis Summary Aptus Endosystems (Aptus), a privately-held medical device company, is engaged in the development of minimally invasive endograft devices, delivery ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2011

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, ?Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2011" provides ...

  • Industries : Drug Discovery and Development
  • Countries : World
Glaucoma Global Clinical Trials Review, H2, 2011

Glaucoma Global Clinical Trials Review, H2, 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Glaucoma Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, ?Glaucoma Global Clinical Trials Review, H2, 2011" provides data on the Glaucoma clinical trial scenario. This ...

  • Industries : Drug Discovery and Development
  • Countries : World
Hemophilia A Global Clinical Trials Review, H2, 2011

Hemophilia A Global Clinical Trials Review, H2, 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Hemophilia A Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, ?Hemophilia A Global Clinical Trials Review, H2, 2011" provides data on the Hemophilia A clinical trial ...

  • Industries : Drug Discovery and Development
  • Countries : World
Uveitis Global Clinical Trials Review, H2, 2011

Uveitis Global Clinical Trials Review, H2, 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Uveitis Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, ?Uveitis Global Clinical Trials Review, H2, 2011" provides data on the Uveitis clinical trial scenario. This ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Hernia Global Clinical Trials Review, H2, 2011

Hernia Global Clinical Trials Review, H2, 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Hernia Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, ?Hernia Global Clinical Trials Review, H2, 2011" provides data on the Hernia clinical trial scenario. This report ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
SUGI Holdings Co., Ltd.: Company Profile and SWOT Analysis

SUGI Holdings Co., Ltd.: Company Profile and SWOT Analysis

  • $ 99
  • Company report
  • October 2011
  • by ICD Research

Synopsis ICD Research's 'SUGI Holdings Co., Ltd.: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, ...

  • Industries : Drug Discovery and Development
  • Countries : Japan
Growth Hormone Deficiency Global Clinical Trials Review, H2 2011

Growth Hormone Deficiency Global Clinical Trials Review, H2 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Growth Hormone Deficiency Global Clinical Trials Review, H2 2011 Summary GlobalData's clinical trial report, ?Growth Hormone Deficiency Global Clinical Trials Review, H2, 2011" provides data on the Growth ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Hepatitis B Global Clinical Trials Review, H2, 2011

Hepatitis B Global Clinical Trials Review, H2, 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Hepatitis B Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, ?Hepatitis B Global Clinical Trials Review, H2, 2011" provides data on the Hepatitis B clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World
Hyperglycemia Global Clinical Trials Review, H2, 2011

Hyperglycemia Global Clinical Trials Review, H2, 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Hyperglycemia Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, ?Hyperglycemia Global Clinical Trials Review, H2, 2011" provides data on the Hyperglycemia clinical trial ...

  • Industries : Drug Discovery and Development
  • Countries : World
Polycystic Ovarian Syndrome Global Clinical Trials Review, H2 2011

Polycystic Ovarian Syndrome Global Clinical Trials Review, H2 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Polycystic Ovarian Syndrome Global Clinical Trials Review, H2 2011 Summary GlobalData's clinical trial report, ?Polycystic Ovarian Syndrome Global Clinical Trials Review, H2, 2011" provides data on the ...

  • Industries : Drug Discovery and Development
  • Countries : World
Barrett's Esophagus Global Clinical Trials Review, H2 2011

Barrett's Esophagus Global Clinical Trials Review, H2 2011

  • $ 1 000
  • Industry report
  • October 2011
  • by Global Data

Barrett's Esophagus Global Clinical Trials Review, H2 2011 Summary GlobalData's clinical trial report, ?Barrett's Esophagus Global Clinical Trials Review, H2, 2011" provides data on the Barrett's Esophagus ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly

Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly

  • $ 3 500
  • Industry report
  • October 2011
  • by GBI Research

Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Drug Discovery and Development
  • Countries : World
UK/Ireland biotechnology sector: clinical phase drug development pipeline

UK/Ireland biotechnology sector: clinical phase drug development pipeline

  • $ 1 484
  • Industry report
  • October 2011
  • by Beremans Ltd

This report identifies all UK / Ireland biotechnology companies with drug candidates that have entered clinical trials. All clinical phase drug candidates being developed by these companies are listed, ...

  • Industries : Drug Discovery and Development
  • Countries : Ireland, United Kingdom

» Read our Company Profiles

About 100 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Johnson and Johnson

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.